Recent publications · Crossref
5 total works indexed
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
· 2018 · cited 3,116x
- First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
· 2021 · cited 1,082x
- Properties and performance of the prototype instrument for the Pierre Auger Observatory
· 2004 · cited 569x
- Highly efficient p-i-n perovskite solar cells that endure temperature variations
· 2023 · cited 558x
- A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407
· 2020 · cited 539x
via Crossref · CC0